A series of rhodium and iridium complexes derived from lutidine-based ligands (lutidine, 2,6-dimethylpyridine) with NHC and amino side-donor functions have been prepared and characterized. Deprotonation of the functionalized imidazolium salts, [ t BuHImCH 2 PyCH 2 NR 2 ]Br, by the bridging methoxo ligands of the dinuclear complexes [M(μ-OMe)(cod)] 2 affords [MBr-(cod)(κC-t BuImCH 2 PyCH 2 NR 2 )] (M = Rh and Ir) complexes from which a series of Rh(I) and Ir(I) complexes including [are readily accessible by halide abstraction and/or carbonylation reactions. In contrast, direct metalation of imidazolium salts with the dinuclear compounds [M(μ-Cl)(cod)] 2 (M = Rh and Ir) in the presence of potassium acetate and potassium iodide, a well-established synthetic route to M(III) species, provides access to unusual di-iodido M(III) cyclometalated compounds [MI 2 {κ 4 C,C′,N,N′-(CH 2 CMe 2 ImCH 2 PyCH 2 NR 2 )}] in low yield. Experimental studies combined with DFT calculations suggest that cyclometalated M(III) hydrido [MH(CH 3 CN){κ 4 C,C′,N,N′-(CH 2 CMe 2 ImCH 2 PyCH 2 NR 2 )}] + compounds and square-planar cyclometalated M(I) [M{κ 4 C,C′,N,N′-(CH 2 CMe 2 ImCH 2 PyCH 2 NR 2 )}] species resulting from their deprotonation by acetate could be intermediates involved in the formation of these compounds. Based on the observed formation of elemental rhodium, disproportionation of square-planar cyclometalated M(I) complexes to afford M(0) and the cationic M(II) species [M{κ 4 C,C′,N,N′-(CH 2 CMe 2 ImCH 2 PyCH 2 NR 2 )}] + is proposed. Reaction of the latter with iodide (I − ) would regenerate the M(I) intermediate to give an iodo radical (I•) that in turn could dimerize to form diiodine I 2 . In this regard, DFT calculations have shown that the oxidative addition of diiodine to the cyclometalated M(I) intermediates leading to the di-iodido M(III) cyclometalated compounds is a highly exergonic process.